Clinical Trials Directory

Trials / Completed

CompletedNCT01836510

Selection of Potential Predictors of Worsening Heart Failure

Status
Completed
Phase
Study type
Observational
Enrollment
922 (actual)
Sponsor
Biotronik SE & Co. KG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multicentre study with the objective to correlate heart failure hospitalizations and deaths with Home Monitoring data in ICD/CRT-D recipients, in order to identify the combination of Home Monitoring data with the greatest sensitivity and specificity in predicting Heart Failure events. All data are prospectively collected.

Detailed description

Home Monitoring remotely provides continuous trends of potential HF-related variables with a sampling interval of 24 hours. Although the predictive value of individual variables may be limited, a proper combination of more variables and their 24-hour sampling may allow developing a HM diagnostic algorithm to accurately predict HF worsening within given time windows. The objective of this Study is to select the predictive variables which are most likely to be effectively included in a future algorithm. This is a multicentre, exploratory Study with the objective to prospectively collect follow-up and Home Monitoring data from a population of subjects with indication for ICD and/or CRT-D implantation, to document HF hospitalizations and deaths and to correlate these events with HM data to identify the combination of HM data with the greatest sensitivity and specificity in predicting HF events. Fifty first hospitalizations for worsening HF (adjudicated by an independent board) are necessary to reach the study objective (Event driven study), which were initially assumed to be generated by 650 patients fulfilling inclusion and exclusion criteria. Sample size estimation has been reviewed after an interim analysis.

Conditions

Timeline

Start date
2012-05-01
Primary completion
2017-02-28
Completion
2017-02-28
First posted
2013-04-22
Last updated
2020-01-18

Locations

34 sites across 2 countries: Italy, Spain

Source: ClinicalTrials.gov record NCT01836510. Inclusion in this directory is not an endorsement.